Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
8.83
+0.12 (1.38%)
At close: Aug 14, 2026, 4:00 PM EDT
8.90
+0.07 (0.79%)
After-hours: Aug 14, 2026, 7:36 PM EDT

Puma Biotechnology Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
231.24228.37230.47235.64228.03253.16
Revenue Growth
-2.86%-0.91%-2.19%3.34%-9.92%12.46%
Gross Profit
173.05170.21166.06172.96172.94189.45
Operating Income
30.4437.330.9732.6430.721.29
Net Income
26.7231.1130.2821.590-29.13
Earnings Per Share
0.500.610.620.450.00-0.72
EPS Growth
-48.22%-1.61%37.78%1022625.00%--

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
93.997.53100.9795.9481.0782.11
Total Debt
4.8228.5574.08111.49114.28116.64
Net Cash (Debt)
89.0968.9826.88-15.55-33.21-34.54
Net Cash Growth
90.38%156.60%----
Net Cash Per Share
1.721.360.55-0.33-0.74-0.85

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
41.1541.838.9227.01-15.8320.65
Capital Expenditures
0.01-0.07-0.06-0.14--
Free Cash Flow
41.1641.7338.8626.87-15.8320.65
Free Cash Flow Growth
-6.93%7.38%44.64%--2740.44%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
74.83%74.53%72.06%73.40%75.84%74.84%
Operating Margin
13.16%16.33%13.44%13.85%13.47%0.51%
Pretax Margin
13.48%15.67%10.46%9.62%0.20%-11.38%
Profit Margin
11.55%13.62%13.14%9.16%0.00%-11.51%
FCF Margin
17.80%18.27%16.86%11.40%-6.94%8.16%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
17.539.644.959.5498021.07-
Forward PE
30.4512.5511.6210.5733.92127.84
P/FCF Ratio
11.077.193.857.67-6.02
PS Ratio
1.971.310.650.870.860.49